A pilot study evaluating the effects of prestorage leukoreduction on markers of inflammation in critically ill dogs receiving a blood transfusion.
Luis Bosch LozanoShauna L BloisR Darren WoodAnthony C G Abrams-OggAlexa M BersenasShane W BatemanDanielle M RichardsonPublished in: Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001) (2019)
Most markers of inflammation did not significantly increase following transfusion of LR versus non-LR pRBCs stored ≤12 days in ill dogs. Further prospective, randomized trials are needed in clinically ill dogs to determine the benefit of prestorage leukoreduction.